Association of Red Cell Distribution Width to Albumin Ratio (RAR) with Mortality Outcomes in ICU Patients Suffering from Sepsis-Related ARDS: A Retrospective Analysis Utilizing MIMIC-IV Data - Top-Institutions - MDSpire

Association of Red Cell Distribution Width to Albumin Ratio (RAR) with Mortality Outcomes in ICU Patients Suffering from Sepsis-Related ARDS: A Retrospective Analysis Utilizing MIMIC-IV Data

  • By

  • Hongzhou Wu

  • Min He

  • Yujia Gui

  • Jinyi Zhou

  • Liting Yue

  • Xiaoqin Zhang

  • February 28, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical Center

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Pulmonology
    • Infectious Diseases

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Pulmonology
    • Immunology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Pulmonology
    • Nutrition

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Pulmonology
    • Clinical Epidemiology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Critical Care Medicine
    • Pulmonology
    • Clinical Research

Original Source(s)

Association of Red Cell Distribution Width to Albumin Ratio (RAR) with Mortality Outcomes in ICU Patients Suffering from Sepsis-Related ARDS: A Retrospective Analysis Utilizing MIMIC-IV Data

  • by Hongzhou Wu, Min He, Yujia Gui, Jinyi Zhou, Liting Yue, Xiaoqin Zhang

  • February 28, 2026

Related Content

Pharmacological intervention of the HMGB1-pCTS-L axis to ameliorate inflammatory diseases

Neutrophil immunometabolism in ACLF and sepsis: mechanisms, dysfunction, and therapeutic opportunities

Targeting VISTA for immunomodulation in sepsis: mechanisms and therapeutic potentials